STOCK TITAN

AngioDynamics to Report Fiscal 2022 Fourth Quarter and Full-Year Financial Results on July 12, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) will release its financial results for Q4 and fiscal year 2022 on July 12, 2022, before market open. A conference call is scheduled for 8:00 a.m. ET on the same day to discuss the results. Investors can join via phone or through a webcast available on AngioDynamics' website. A recording of the call will be accessible from 11:00 a.m. ET on July 12 until 11:59 p.m. ET on July 19. The company focuses on innovative medical technologies aimed at improving vascular health and cancer treatment.

Positive
  • None.
Negative
  • None.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that it will report financial results for the fourth quarter and fiscal year 2022 before the market open on Tuesday, July 12, 2022. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13730672.

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 11:00 a.m. ET on Tuesday, July 12, 2022, until 11:59 p.m. ET on Tuesday, July 19, 2022. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13730672.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

Investor Contact:



AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics report its financial results for Q4 2022?

AngioDynamics will report its financial results for Q4 2022 on July 12, 2022.

What time is the AngioDynamics conference call scheduled for?

The AngioDynamics conference call is scheduled for 8:00 a.m. ET on July 12, 2022.

How can I access the AngioDynamics conference call?

You can access the AngioDynamics conference call by dialing 1-877-407-0784 (domestic) or +1-201-689-8560 (international) with the passcode 13730672, or via the webcast on their website.

When will the recording of the AngioDynamics call be available?

The recording of the AngioDynamics call will be available from 11:00 a.m. ET on July 12, 2022, until 11:59 p.m. ET on July 19, 2022.

AngioDynamics, Inc.

NASDAQ:ANGO

ANGO Rankings

ANGO Latest News

ANGO Stock Data

357.18M
38.36M
5.61%
81.33%
2.79%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
LATHAM